← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 6, 2020Last known activity
Jul 6, 2023
Acquired by Aileron Therapeutics on Oct 31, 2023
Timeline
2010s
- Jan 1, 2013
Lung Therapeutics, Inc— Founded
2020s
- Oct 31, 2023
Aileron Therapeutics— Acquired By
Drugs by trial phase (2 distinct, 3 trials)
Indications
Recent trials (3)
- NCT05954988Lead sponsorPhase 1Jul 6, 2023
- NCT04159831Lead sponsorPhase 2Jan 31, 2020
- NCT04233814Lead sponsorPhase 1Jan 6, 2020
Details
- Founded
- Austin, TX, US Jan 1, 2013
- Last known activity
- Jul 6, 2023